Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response

PLoS Pathogens

Volumn 7, Issue 4, 2011, Pages

  Munir, Shirin ^a   Hillyer, Philippa ^b   le Nouën, Cyril ^a   Buchholz, Ursula J ^a   Rabin, Ronald L ^b   Collins, Peter L ^a   Bukreyev, Alexander ^a,c  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; CD11 ANTIGEN; CD14 ANTIGEN; CD38 ANTIGEN; CYTOKINE; ENHANCED GREEN FLUORESCENT PROTEIN; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 2; T6 ANTIGEN; ALPHA E INTEGRINS; ALPHA INTEGRIN; LEUKOCYTE ANTIGEN; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; DELETION MUTANT; DENDRITIC CELL; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE DELETION; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; NEUTROPHIL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; T LYMPHOCYTE; TH1 CELL; TH17 CELL; VERO CELL; VIROGENESIS; VIRUS PURIFICATION; ADULT; DRUG ANTAGONISM; FEMALE; GENETICS; IMMUNOLOGY; MALE; METABOLISM; RESPIRATORY SYNCYTIAL VIRUS INFECTION; UPREGULATION; VIROLOGY;

ACETYLCYSTEINE; ANTIVIRAL AGENTS; AXONEMAL DYNEINS; BRONCHI; CELL DIFFERENTIATION; CELLS, CULTURED; CILIA; EPITHELIAL CELLS; FORKHEAD TRANSCRIPTION FACTORS; FREE RADICAL SCAVENGERS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-13; MICROSCOPY, VIDEO; MUCIN 5AC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; TUBULIN; VIRUS REPLICATION; ADULT; ANTIGENS, CD; CELL PROLIFERATION; CYTOKINES; DENDRITIC CELLS; FEMALE; INTEGRIN ALPHA CHAINS; INTERFERONS; MALE; RESPIRATORY SYNCYTIAL VIRUSES; T-LYMPHOCYTES; UP-REGULATION; VIRAL NONSTRUCTURAL PROTEINS;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 79955758958     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1001336     Document Type: Article

References (90)

1. Garcia-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, et al. (1998) Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252: 324-330.
2. Weber F, Haller O, (2007) Viral suppression of the interferon system. Biochimie 89: 836-842.
3. Tough DF, (2004) Type I interferon as a link between innate and adaptive immunity through dendritic cell stimulation. Leuk Lymphoma 45: 257-264.
4. Fujita H, Asahina A, Tada Y, Fujiwara H, Tamaki K, (2005) Type I interferons inhibit maturation and activation of mouse Langerhans cells. J Invest Dermatol 125: 126-133.
5. von Hoegen P, Zawatzky R, Schirrmacher V, (1990) Modification of tumor cells by a low dose of Newcastle disease virus. III. Potentiation of tumor-specific cytolytic T cell activity via induction of interferon-alpha/beta. Cell Immunol 126: 80-90.
6. Thompson LJ, Kolumam GA, Thomas S, Murali-Krishna K, (2006) Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. J Immunol 177: 1746-1754.
7. Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K, (2005) Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 202: 637-650.
8. Havenar-Daughton C, Kolumam GA, Murali-Krishna K, (2006) Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J Immunol 176: 3315-3319.
9. Tough DF, Borrow P, Sprent J, (1996) Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272: 1947-1950.
10. Gallagher KM, Lauder S, Rees IW, Gallimore AM, Godkin AJ, (2009) Type I interferon (IFN alpha) acts directly on human memory CD4+ T cells altering their response to antigen. J Immunol 183: 2915-2920.
11. Lachgar A, Bizzini B, (1994) Involvement of alpha-interferon in HIV-1 induced immunosuppression. A potential target for AIDS prophylaxis and treatment. Biomed Pharmacother 48: 73-77.
12. Erickson S, Matikainen S, Thyrell L, Sangfelt O, Julkunen I, et al. (2002) Interferon-alpha inhibits Stat5 DNA-binding in IL-2 stimulated primary T-lymphocytes. Eur J Biochem 269: 29-37.
13. Schmidlin H, Dontje W, Groot F, Ligthart SJ, Colantonio AD, et al. (2006) Stimulated plasmacytoid dendritic cells impair human T-cell development. Blood 108: 3792-3800.
14. Zagury D, Lachgar A, Chams V, Fall LS, Bernard J, et al. (1998) Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. Proc Natl Acad Sci U S A 95: 3851-3856.
15. Chi B, Dickensheets HL, Spann KM, Alston MA, Luongo C, et al. (2006) Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus. J Virol 80: 5032-5040.
16. Collins PL, Crowe JEJ, (2007) Respiratory Syncytial Virus and Metapneumovirus. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA et al, editors. Fields Virology. 5 ed Philadelphia Lippincott-Raven Publishers pp. 1601-1646.
17. Collins PL, Graham BS, (2008) Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol 82: 2040-2055.
18. Hall CB, Walsh EE, Long CE, Schnabel KC, (1991) Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis 163: 693-698.
19. Henderson FW, Collier AM, Clyde WA Jr, Denny FW, (1979) Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N Engl J Med 300: 530-534.
20. Bukreyev A, Yang L, Fricke J, Cheng L, Ward JM, et al. (2008) The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes. J Virol 82: 12191-12204.
21. Bossert B, Marozin S, Conzelmann KK, (2003) Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3. J Virol 77: 8661-8668.
22. Elliott J, Lynch OT, Suessmuth Y, Qian P, Boyd CR, et al. (2007) Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase. J Virol 81: 3428-3436.
23. Lo MS, Brazas RM, Holtzman MJ, (2005) Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J Virol 79: 9315-9319.
24. Spann KM, Tran KC, Chi B, Rabin RL, Collins PL, (2004) Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected]. J Virol 78: 4363-4369.
25. Spann KM, Tran KC, Collins PL, (2005) Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines. J Virol 79: 5353-5362.
26. Ling Z, Tran KC, Teng MN, (2009) Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. J Virol 83: 3734-3742.
27. Bitko V, Shulyayeva O, Mazumder B, Musiyenko A, Ramaswamy M, et al. (2007) Nonstructural Proteins of Respiratory Syncytial Virus Suppress Premature Apoptosis by an NF-{kappa}B-Dependent, Interferon-Independent Mechanism and Facilitate Virus Growth. J Virol 81: 1786-1795.
28. Munir S, Le Nouen C, Luongo C, Buchholz UJ, Collins PL, et al. (2008) Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells. J Virol 82: 8780-8796.
29. Varol C, Landsman L, Fogg DK, Greenshtein L, Gildor B, et al. (2007) Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J Exp Med 204: 171-180.
30. de Bree GJ, van Leeuwen EM, Out TA, Jansen HM, Jonkers RE, et al. (2005) Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung. J Exp Med 202: 1433-1442.
31. Xu Y, Zhan Y, Lew AM, Naik SH, Kershaw MH, (2007) Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. J Immunol 179: 7577-7584.
32. Farrar JD, Smith JD, Murphy TL, Leung S, Stark GR, et al. (2000) Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2. Nat Immunol 1: 65-69.
33. Rogge L, D'Ambrosio D, Biffi M, Penna G, Minetti LJ, et al. (1998) The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J Immunol 161: 6567-6574.
34. Le Floc'h A, Jalil A, Vergnon I, Le Maux Chansac B, Lazar V, et al. (2007) Alpha E beta 7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis. J Exp Med 204: 559-570.
35. Rihs S, Walker C, Virchow JC Jr, Boer C, Kroegel C, et al. (1996) Differential expression of alpha E beta 7 integrins on bronchoalveolar lavage T lymphocyte subsets: regulation by alpha 4 beta 1-integrin crosslinking and TGF-beta. Am J Respir Cell Mol Biol 15: 600-610.
36. Cepek KL, Shaw SK, Parker CM, Russell GJ, Morrow JS, et al. (1994) Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature 372: 190-193.
37. Franciszkiewicz K, Le Floc'h A, Jalil A, Vigant F, Robert T, et al. (2009) Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention. Cancer Res 69: 6249-6255.
38. Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, et al. (2003) Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281: 65-78.
39. Seder RA, Darrah PA, Roederer M, (2008) T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 8: 247-258.
40. Wong P, Pamer EG, (2003) Feedback regulation of pathogen-specific T cell priming. Immunity 18: 499-511.
41. Fukuda M, (1991) Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. J Biol Chem 266: 21327-21330.
42. Abu-Khabar KS, Armstrong JA, Ho M, (1992) Type I interferons (IFN-alpha and-beta) suppress cytotoxin (tumor necrosis factor-alpha and lymphotoxin) production by mitogen-stimulated human peripheral blood mononuclear cell. J Leukoc Biol 52: 165-172.
43. Liu AN, Mohammed AZ, Rice WR, Fiedeldey DT, Liebermann JS, et al. (1999) Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand. Am J Respir Cell Mol Biol 20: 849-858.
44. Ratner A, Clark WR, (1993) Role of TNF-alpha in CD8+ cytotoxic T lymphocyte-mediated lysis. J Immunol 150: 4303-4314.
45. Singh A, Suresh M, (2007) A role for TNF in limiting the duration of CTL effector phase and magnitude of CD8 T cell memory. J Leukoc Biol 82: 1201-1211.
46. Firestein GS, Roeder WD, Laxer JA, Townsend KS, Weaver CT, et al. (1989) A new murine CD4+ T cell subset with an unrestricted cytokine profile. J Immunol 143: 518-525.
47. Hegazy AN, Peine M, Helmstetter C, Panse I, Frohlich A, et al. (2010) Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. Immunity 32: 116-128.
48. Zhu J, Paul WE, (2010) CD4(+) T Cell Plasticity-Th2 Cells Join the Crowd. Immunity 32: 11-13.
49. Bukreyev A, Belyakov IM, Prince GA, Yim KC, Harris KK, et al. (2005) Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus. J Virol 79: 9515-9526.
50. van der Velden VH, Laan MP, Baert MR, de Waal Malefyt R, Neijens HJ, et al. (2001) Selective development of a strong Th2 cytokine profile in high-risk children who develop atopy: risk factors and regulatory role of IFN-gamma, IL-4 and IL-10. Clin Exp Allergy 31: 997-1006.
51. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, et al. (2007) Phenotypic and functional features of human Th17 cells. J Exp Med 204: 1849-1861.
52. Marijanovic Z, Ragimbeau J, van der Heyden J, Uze G, Pellegrini S, (2007) Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2. Biochem J 407: 141-151.
53. Izaguirre A, Barnes BJ, Amrute S, Yeow WS, Megjugorac N, et al. (2003) Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells. J Leukoc Biol 74: 1125-1138.
54. Graham BS, Bunton LA, Wright PF, Karzon DT, (1991) Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest 88: 1026-1033.
55. Fishaut M, Tubergen D, McIntosh K, (1980) Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity. J Pediatr 96: 179-186.
56. Woodberry T, Suscovich TJ, Henry LM, August M, Waring MT, et al. (2005) Alpha E beta 7 (CD103) expression identifies a highly active, tonsil-resident effector-memory CTL population. J Immunol 175: 4355-4362.
57. Smyth LJ, Kirby JA, Cunningham AC, (2007) Role of the mucosal integrin alpha(E)(CD103)beta(7) in tissue-restricted cytotoxicity. Clin Exp Immunol 149: 162-170.
58. O'Quinn DB, Palmer MT, Lee YK, Weaver CT, (2008) Emergence of the Th17 pathway and its role in host defense. Adv Immunol 99: 115-163.
59. Kolls JK, Linden A, (2004) Interleukin-17 family members and inflammation. Immunity 21: 467-476.
60. Wiehler S, Proud D, (2007) Interleukin-17A modulates human airway epithelial responses to human rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 293: L505-515.
61. Fujisawa H, (2008) Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice. J Virol 82: 2772-2783.
62. Sporri R, Joller N, Hilbi H, Oxenius A, (2008) A novel role for neutrophils as critical activators of NK cells. J Immunol 181: 7121-7130.
63. Pepper M, Linehan JL, Pagan AJ, Zell T, Dileepan T, et al. (2010) Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat Immunol 11: 83-89.
64. Kohyama S, Ohno S, Isoda A, Moriya O, Belladonna ML, et al. (2007) IL-23 enhances host defense against vaccinia virus infection via a mechanism partly involving IL-17. J Immunol 179: 3917-3925.
65. McKinstry KK, Strutt TM, Buck A, Curtis JD, Dibble JP, et al. (2009) IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J Immunol 182: 7353-7363.
66. Becker Y, (2006) Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy-a review. Virus Genes 33: 235-252.
67. Miyairi I, DeVincenzo JP, (2008) Human genetic factors and respiratory syncytial virus disease severity. Clin Microbiol Rev 21: 686-703.
68. Choi EH, Lee HJ, Yoo T, Chanock SJ, (2002) A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children. J Infect Dis 186: 1207-1211.
69. Hoebee B, Rietveld E, Bont L, Oosten M, Hodemaekers HM, et al. (2003) Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms. J Infect Dis 187: 2-11.
70. Ermers MJ, Hoebee B, Hodemaekers HM, Kimman TG, Kimpen JL, et al. (2007) IL-13 genetic polymorphism identifies children with late wheezing after respiratory syncytial virus infection. J Allergy Clin Immunol 119: 1086-1091.
71. Forton JT, Rowlands K, Rockett K, Hanchard N, Herbert M, et al. (2009) Genetic association study for RSV bronchiolitis in infancy at the 5q31 cytokine cluster. Thorax 64: 345-352.
72. Zhang W, Yang H, Kong X, Mohapatra S, San Juan-Vergara H, et al. (2005) Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat Med 11: 56-62.
73. Parronchi P, De Carli M, Manetti R, Simonelli C, Sampognaro S, et al. (1992) IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J Immunol 149: 2977-2983.
74. Brinkmann V, Geiger T, Alkan S, Heusser CH, (1993) Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J Exp Med 178: 1655-1663.
75. Lopez CB, Garcia-Sastre A, Williams BR, Moran TM, (2003) Type I interferon induction pathway, but not released interferon, participates in the maturation of dendritic cells induced by negative-strand RNA viruses. J Infect Dis 187: 1126-1136.
76. Berghall H, Siren J, Sarkar D, Julkunen I, Fisher PB, et al. (2006) The interferon-inducible RNA helicase, mda-5, is involved in measles virus-induced expression of antiviral cytokines. Microbes Infect 8: 2138-2144.
77. Padovan E, Spagnoli GC, Ferrantini M, Heberer M, (2002) IFN-alpha2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells. J Leukoc Biol 71: 669-676.
78. Wuest T, Austin BA, Uematsu S, Thapa M, Akira S, et al. (2006) Intact TRL 9 and type I interferon signaling pathways are required to augment HSV-1 induced corneal CXCL9 and CXCL10. J Neuroimmunol 179: 46-52.
79. Kaiko GE, Horvat JC, Beagley KW, Hansbro PM, (2008) Immunological decision-making: how does the immune system decide to mount a helper T-cell response? Immunology 123: 326-338.
80. Bettelli E, Korn T, Oukka M, Kuchroo VK, (2008) Induction and effector functions of T(H)17 cells. Nature 453: 1051-1057.
81. McRae BL, Semnani RT, Hayes MP, van Seventer GA, (1998) Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J Immunol 160: 4298-4304.
82. Rudd BD, Luker GD, Luker KE, Peebles RS, Lukacs NW, (2007) Type I interferon regulates respiratory virus infected dendritic cell maturation and cytokine production. Viral Immunol 20: 531-540.
83. Hussell T, Baldwin CJ, O'Garra A, Openshaw PJ, (1997) CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur J Immunol 27: 3341-3349.
84. Srikiatkhachorn A, Braciale TJ, (1997) Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J Exp Med 186: 421-432.
85. Culley FJ, Pollott J, Openshaw PJ, (2002) Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J Exp Med 196: 1381-1386.
86. Le Nouen C, Hillyer P, Munir S, Winter CC, McCarty T, et al. (2010) Effects of human respiratory syncytial virus, metapneumovirus, parainfluenza virus 3 and influenza virus on CD4+ T cell activation by dendritic cells. PLoS One 5: e15017.
87. Murphy BR, Sotnikov AV, Lawrence LA, Banks SM, Prince GA, (1990) Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization. Vaccine 8: 497-502.
88. Schuurhuis DH, Fu N, Ossendorp F, Melief CJ, (2006) Ins and outs of dendritic cells. Int Arch Allergy Immunol 140: 53-72.
89. Le Nouen C, Hillyer P, Munir S, Winter CC, McCarty T, et al. (2010) Effects of human respiratory syncytial virus, metapneumovirus, parainfluenza virus 3 and influenza virus on CD4+ T cell activation by dendritic cells. PLoS One 5: e15017.
90. Jaks E, Gavutis M, Uze G, Martal J, Piehler J, (2007) Differential receptor subunit affinities of type I interferons govern differential signal activation. J Mol Biol 366: 525-539.